{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:17:09Z","timestamp":1780453029277,"version":"3.54.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T00:00:00Z","timestamp":1500508800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s11239-017-1529-6","type":"journal-article","created":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T01:36:33Z","timestamp":1500514593000},"page":"303-315","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Benefits and risks of P2Y12 inhibitor preloading in patients with acute coronary syndrome and stable angina"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6779-4867","authenticated-orcid":false,"given":"Taylor C.","family":"Bazemore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Nanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil V.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,20]]},"reference":[{"issue":"7","key":"1529_CR1","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","volume":"345","author":"S Yusuf","year":"2001","unstructured":"Yusuf S, Bijsterveld N, Moons A (2001) Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation: the clopidogrel in unstable angina to prevent recurrent events trial investigators. New Engl J Med 345(7):494\u2013502","journal-title":"New Engl J Med"},{"issue":"23","key":"1529_CR2","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJM199812033392303","volume":"339","author":"MB Leon","year":"1998","unstructured":"Leon MB, Baim DS, Popma JJ, Gordon PC, Cutlip DE, Ho KK, Giambartolomei A, Diver DJ, Lasorda DM, Williams DO (1998) A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. New Engl J Med 339(23):1665\u20131671","journal-title":"New Engl J Med"},{"issue":"9281","key":"1529_CR3","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","volume":"358","author":"SR Mehta","year":"2001","unstructured":"Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Natarajan MK, Malmberg K, Rupprecht H-J, Zhao F, Chrolavicius S (2001) Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358(9281):527\u2013533","journal-title":"Lancet"},{"issue":"23","key":"1529_CR4","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1093\/eurheartj\/ehr360","volume":"32","author":"J D\u00f6rler","year":"2011","unstructured":"D\u00f6rler J, Edlinger M, Alber HF, Altenberger J, Benzer W, Grimm G, Huber K, Pachinger O, Schuchlenz H, Siostrzonek P, Zenker G, Weidinger F, Altenberger J, Pichler M, Benzer W, Bonner G, Weidinger F, Brunner T, Gaul G, Gratze F, Zenker G, Juhasz M, Silberbauer H, Kerschner K, Leisch F, Krappinger H, Wimmer H, Laubreiter K, Grimm G, Siostrzonek P, Mayr H, Neunteufl T, Maurer G, Norman G, Weber H, Pachinger O, D\u00f6rler J, Alber HF, Roithinger FX, Unger G, Huber K, Wallner H, Weihs W, Schuchlenz H (2011) Clopidogrel pre-treatment is associated with reduced in-hospital mortality in primary percutaneous coronary intervention for acute ST-elevation myocardial infarction. Eur Heart J 32(23):2954\u20132961. doi:\n                        10.1093\/eurheartj\/ehr360","journal-title":"Eur Heart J"},{"key":"1529_CR5","doi-asserted-by":"crossref","first-page":"g6269","DOI":"10.1136\/bmj.g6269","volume":"349","author":"A Bellemain-Appaix","year":"2014","unstructured":"Bellemain-Appaix A, Kerneis M, O\u2019Connor SA, Silvain J, Cucherat M, Beygui F, Barth\u00e9l\u00e9my O, Collet J-P, Jacq L, Bernasconi F (2014) Reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome: a systematic review and meta-analysis. BMJ 349:g6269","journal-title":"BMJ"},{"issue":"7","key":"1529_CR6","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jacc.2010.01.067","volume":"56","author":"G Di Sciascio","year":"2010","unstructured":"Di Sciascio MG, Patti G, Pasceri V, Gatto L (2010) Effectiveness of in-laboratory high-dose clopidogrel loading versus routine pre-load in patients undergoing percutaneous coronary intervention. J Am Coll Cardiol 56(7):550\u2013557","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"1529_CR7","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa1308075","volume":"369","author":"G Montalescot","year":"2013","unstructured":"Montalescot G, Bolognese L, Dudek D, Goldstein P, Hamm C, Tanguay J-F, ten Berg JM, Miller DL, Costigan TM, Goedicke J (2013) Pretreatment with prasugrel in non\u2013ST-segment elevation acute coronary syndromes. New Engl J Med 369(11):999\u20131010","journal-title":"New Engl J Med"},{"issue":"11","key":"1529_CR8","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1056\/NEJMoa1407024","volume":"371","author":"G Montalescot","year":"2014","unstructured":"Montalescot G, van\u2019t Hof AW, Lapostolle F, Silvain J, Lassen JF, Bolognese L, Cantor WJ, Cequier \u00c1, Chettibi M, Goodman SG (2014) Prehospital ticagrelor in ST-segment elevation myocardial infarction. New Engl J Med 371(11):1016\u20131027","journal-title":"New Engl J Med"},{"issue":"21","key":"1529_CR9","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1161\/CIRCULATIONAHA.114.011320","volume":"130","author":"J-P Collet","year":"2014","unstructured":"Collet J-P, Silvain J, Bellemain-Appaix A, Montalescot G (2014) Pretreatment with P2Y12 Inhibitors in non-ST-segment-elevation acute coronary syndrome: an outdated and harmful strategy. Circulation 130(21):1904\u20131914","journal-title":"Circulation"},{"issue":"17","key":"1529_CR10","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.2146\/ajhp100008","volume":"67","author":"BB Dean","year":"2010","unstructured":"Dean BB, Yu H-T, Bae JP, Fiske S, Meadows E, Xiong Y, Emons MF (2010) Pattern of clopidogrel use in hospitalized patients receiving percutaneous coronary interventions. Am J Health Syst Pharm 67(17):1430\u20131437","journal-title":"Am J Health Syst Pharm"},{"issue":"11","key":"1529_CR11","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","volume":"361","author":"L Wallentin","year":"2009","unstructured":"Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. New Engl J Med 361(11):1045\u20131057","journal-title":"New Engl J Med"},{"issue":"9665","key":"1529_CR12","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(09)60441-4","volume":"373","author":"G Montalescot","year":"2009","unstructured":"Montalescot G, Wiviott SD, Braunwald E, Murphy SA, Gibson CM, McCabe CH, Antman EM, investigators T-T (2009) Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial. Lancet 373(9665):723\u2013731","journal-title":"Lancet"},{"key":"1529_CR13","first-page":"ehv717","volume":"16","author":"D Sibbing","year":"2015","unstructured":"Sibbing D, Kastrati A, Berger PB (2015) Pre-treatment with P2Y12 inhibitors in ACS patients: who, when, why, and which agent? Eur Heart J 16:ehv717","journal-title":"Eur Heart J"},{"issue":"8","key":"1529_CR14","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1517\/14656566.2011.550573","volume":"12","author":"MA Giorgi","year":"2011","unstructured":"Giorgi MA, Cohen Arazi H, Gonzalez CD, Di Girolamo G (2011) Beyond efficacy: pharmacokinetic differences between clopidogrel, prasugrel and ticagrelor. Expert Opin Pharmacother 12(8):1285\u20131295","journal-title":"Expert Opin Pharmacother"},{"issue":"10","key":"1529_CR15","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/phar.1477","volume":"34","author":"PP Dobesh","year":"2014","unstructured":"Dobesh PP, Oestreich JH (2014) TicagrelOR pharmacokinetics, pharmacodynamics, clinical efficacy, and safety. Pharmacotherapy 34(10):1077\u20131090","journal-title":"Pharmacotherapy"},{"issue":"1","key":"1529_CR16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2125.2010.03669.x","volume":"70","author":"K Butler","year":"2010","unstructured":"Butler K, Teng R (2010) Pharmacokinetics, pharmacodynamics, safety and tolerability of multiple ascending doses of ticagrelor in healthy volunteers. Br J Clin Pharmacol 70(1):65\u201377","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"1529_CR17","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1586\/erc.09.101","volume":"7","author":"JL Ferreiro","year":"2009","unstructured":"Ferreiro JL, Ueno M, Angiolillo DJ (2009) CangrelOR a review on its mechanism of action and clinical development. Expert Rev Cardiovasc Ther 7(10):1195\u20131201","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"10","key":"1529_CR18","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1001\/jama.294.10.1224","volume":"294","author":"MS Sabatine","year":"2005","unstructured":"Sabatine MS, Cannon CP, Gibson CM, L\u00f3pez-Send\u00f3n JL, Montalescot G, Theroux P, Lewis BS, Murphy SA, McCabe CH, Braunwald E (2005) Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study. JAMA 294(10):1224\u20131232","journal-title":"JAMA"},{"issue":"4","key":"1529_CR19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00392-011-0393-1","volume":"101","author":"U Zeymer","year":"2012","unstructured":"Zeymer U, Arntz H-R, Mark B, Fichtlscherer S, Werner G, Sch\u00f6ller R, Zahn R, Diller F, Darius H, Dill T (2012) Efficacy and safety of a high loading dose of clopidogrel administered prehospitally to improve primary percutaneous coronary intervention in acute myocardial infarction: the randomized CIPAMI trial. Clin Res Cardiol 101(4):305\u2013312","journal-title":"Clin Res Cardiol"},{"issue":"5","key":"1529_CR20","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1016\/j.ijcard.2013.07.012","volume":"168","author":"K Ducci","year":"2013","unstructured":"Ducci K, Grotti S, Falsini G, Angioli P, Liistro F, Mand\u00f2 M, Porto I, Bolognese L (2013) Comparison of pre-hospital 600\u00a0mg or 900\u00a0mg versus peri-interventional 300\u00a0mg clopidogrel in patients with ST-elevation myocardial infarction undergoing primary coronary angioplasty. The Load&Go randomized trial. Int J Cardiol 168(5):4814","journal-title":"Int J Cardiol"},{"issue":"19","key":"1529_CR21","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","volume":"288","author":"SR Steinhubl","year":"2002","unstructured":"Steinhubl SR, Berger PB, Mann IJ et al (2002) Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 288(19):2411\u20132420. doi:\n                        10.1001\/jama.288.19.2411","journal-title":"JAMA"},{"issue":"4","key":"1529_CR22","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.amjcard.2007.09.089","volume":"101","author":"EI Lev","year":"2008","unstructured":"Lev EI, Kornowski R, Vaknin-Assa H, Brosh D, Fuchs S, Battler A, Assali A (2008) Effect of clopidogrel pretreatment on angiographic and clinical outcomes in patients undergoing primary percutaneous coronary intervention for ST-elevation acute myocardial infarction. Am J Cardiol 101(4):435\u2013439","journal-title":"Am J Cardiol"},{"issue":"2","key":"1529_CR23","first-page":"110","volume":"3","author":"S Waha de","year":"2014","unstructured":"de Waha S, Eitel I, Desch S, Fuernau G, Lurz P, Schuler G, Thiele H (2014) Association of upstream clopidogrel administration and myocardial reperfusion assessed by cardiac magnetic resonance imaging in patients with ST-elevation myocardial infarction. Eur Heart J 3(2):110\u2013117","journal-title":"Eur Heart J"},{"issue":"4","key":"1529_CR24","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.amjcard.2009.04.013","volume":"104","author":"P Fefer","year":"2009","unstructured":"Fefer P, Hod H, Hammerman H, Segev A, Beinart R, Boyko V, Behar S, Matetzky S (2009) Usefulness of pretreatment with high-dose clopidogrel in patients undergoing primary angioplasty for ST-elevation myocardial infarction. Am J Cardiol 104(4):514\u2013518","journal-title":"Am J Cardiol"},{"issue":"23","key":"1529_CR25","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1093\/eurheartj\/ehr202","volume":"32","author":"S Koul","year":"2011","unstructured":"Koul S, Smith JG, Scherst\u00e9n F, James S, Lagerqvist B, Erlinge D (2011) Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Eur Heart J 32(23):2989\u20132997","journal-title":"Eur Heart J"},{"issue":"1","key":"1529_CR26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/eurheartj\/ehq276","volume":"32","author":"DG Katritsis","year":"2011","unstructured":"Katritsis DG, Siontis GC, Kastrati A, van\u2019t Hof AW, Neumann F-J, Siontis KC, Ioannidis JP (2011) Optimal timing of coronary angiography and potential intervention in non-ST-elevation acute coronary syndromes. Eur Heart J 32(1):32\u201340","journal-title":"Eur Heart J"},{"issue":"7","key":"1529_CR27","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/S0735-1097(03)00944-6","volume":"42","author":"AW Chan","year":"2003","unstructured":"Chan AW, Moliterno DJ, Berger PB, Stone GW, DiBattiste PM, Yakubov SL, Sapp SK, Wolski K, Bhatt DL, Topol EJ (2003) Triple antiplatelet therapy during percutaneous coronary intervention is associated withimproved outcomes including one-year survival results from the do tirofiban and reoprogive similar efficacy outcome trial (TARGET). J Am Coll Cardiol 42(7):1188\u20131195. doi:\n                        10.1016\/S0735-1097(03)00944-6","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"1529_CR28","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/CIRCULATIONAHA.110.958041","volume":"123","author":"TY Wang","year":"2011","unstructured":"Wang TY, White JA, Tricoci P, Giugliano RP, Zeymer U, Harrington RA, Montalescot G, James SK, Van de Werf F, Armstrong PW (2011) Upstream clopidogrel use and the efficacy and safety of early eptifibatide treatment in patients with acute coronary syndrome an analysis from the early glycoprotein IIb\/IIIa inhibition in patients with non-ST-segment elevation acute coronary syndrome (EARLY ACS) trial. Circulation 123(7):722\u2013730","journal-title":"Circulation"},{"issue":"6","key":"1529_CR29","first-page":"1194","volume":"44","author":"J Saw","year":"2004","unstructured":"Saw J, Lincoff AM, DeSmet W, Betriu A, Rutsch W, Wilcox RG, Kleiman NS, Wolski K, Topol EJ (2004) Lack of clopidogrel pretreatment effect on the relative efficacy of bivalirudin with provisional glycoprotein IIb\/IIIa blockade compared to heparin with routine glycoprotein IIb\/IIIa blockade: a REPLACE-2 substudy. J Am Coll Cardiol 44(6):1194\u20131199","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1529_CR30","first-page":"639","volume":"1","author":"AM Lincoff","year":"2008","unstructured":"Lincoff AM, Steinhubl SR, Manoukian SV, Chew D, Pollack CV, Feit F, Ware JH, Bertrand ME, Ohman EM, Desmet W (2008) Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non\u2013ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. JACC 1(6):639\u2013648","journal-title":"JACC"},{"issue":"2","key":"1529_CR31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ahj.2006.10.030","volume":"153","author":"T Sz\u00fck","year":"2007","unstructured":"Sz\u00fck T, Gy\u00f6ngy\u00f6si M, Homorodi N, Krist\u00f3f \u00c8, Kir\u00e1ly C, \u00c8des IF, Facsk\u00f3 A, Pavo N, Sodeck G, Strehblow C (2007) Effect of timing of clopidogrel administration on 30-day clinical outcomes: 300-mg loading dose immediately after coronary stenting versus pretreatment 6 to 24\u00a0h before stenting in a large unselected patient cohort. Am Heart J 153(2):289\u2013295","journal-title":"Am Heart J"},{"issue":"21","key":"1529_CR32","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1161\/CIRCULATIONAHA.114.011319","volume":"130","author":"M Valgimigli","year":"2014","unstructured":"Valgimigli M (2014) Pretreatment with P2Y12 inhibitors in non\u2013ST-segment-elevation acute coronary syndrome is clinically justified. Circulation 130(21):1891\u20131903","journal-title":"Circulation"},{"issue":"24","key":"1529_CR33","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1056\/NEJMoa0908629","volume":"361","author":"DL Bhatt","year":"2009","unstructured":"Bhatt DL, Lincoff AM, Gibson CM, Stone GW, McNulty S, Montalescot G, Kleiman NS, Goodman SG, White HD, Mahaffey KW (2009) Intravenous platelet blockade with cangrelor during PCI. New Engl J Med 361(24):2330\u20132341","journal-title":"New Engl J Med"},{"issue":"24","key":"1529_CR34","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1056\/NEJMoa0908628","volume":"361","author":"RA Harrington","year":"2009","unstructured":"Harrington RA, Stone GW, McNulty S, White HD, Lincoff AM, Gibson CM, Pollack CV Jr, Montalescot G, Mahaffey KW, Kleiman NS (2009) Platelet inhibition with cangrelor in patients undergoing PCI. New Engl J Med 361(24):2318\u20132329","journal-title":"New Engl J Med"},{"issue":"14","key":"1529_CR35","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1056\/NEJMoa1300815","volume":"368","author":"DL Bhatt","year":"2013","unstructured":"Bhatt DL, Stone GW, Mahaffey KW, Gibson CM, Steg PG, Hamm CW, Price MJ, Leonardi S, Gallup D, Bramucci E (2013) Effect of platelet inhibition with cangrelor during PCI on ischemic events. New Engl J Med 368(14):1303\u20131313","journal-title":"New Engl J Med"},{"issue":"5","key":"1529_CR36","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jacc.2005.10.047","volume":"47","author":"SR Steinhubl","year":"2006","unstructured":"Steinhubl SR, Berger PB, Brennan DM, Topol EJ (2006) Optimal timing for the initiation of pre-treatment with 300\u00a0mg clopidogrel before percutaneous coronary intervention. J Am Coll Cardiol 47(5):939\u2013943","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"1529_CR37","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1093\/eurheartj\/ehn169","volume":"29","author":"P Widimsk\u00fd","year":"2008","unstructured":"Widimsk\u00fd P, Motovsk\u00e1 Z, \u0160imek S, Kala P, Pudil R, Holm F, Petr R, B\u00edlkov\u00e1 D, Skalick\u00e1 H, Kuchynka P, Poloczek M, Mikl\u00edk R, Mal\u00fd M, Aschermann M (2008) Clopidogrel pre-treatment in stable angina: for all patients > 6\u00a0h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI? A randomized multicentre trial PRAGUE-8. Eur Heart J 29(12):1495\u20131503. doi:\n                        10.1093\/eurheartj\/ehn169","journal-title":"Eur Heart J"},{"issue":"1","key":"1529_CR38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jacc.2004.02.056","volume":"44","author":"DJ Heijden van der","year":"2004","unstructured":"van der Heijden DJ, Westendorp IC, Riezebos RK, Kiemeneij F, Slagboom T, van der Wieken LR, Laarman G-J (2004) Lack of efficacy of clopidogrel pre-treatment in the prevention of myocardial damage after elective stent implantation. J Am Coll Cardiol 44(1):20\u201324","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"1529_CR39","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0002-9149(01)01897-5","volume":"88","author":"AR Assali","year":"2001","unstructured":"Assali AR, Salloum J, Sdringola S, Moustapha A, Ghani M, Hale S, Schroth G, Fujise K, Anderson HV, Smalling RW (2001) Effects of clopidogrel pretreatment before percutaneous coronary intervention in patients treated with glycoprotein IIb\/IIIa inhibitors (abciximab or tirofiban). Am J Cardiol 88(8):884\u2013886","journal-title":"Am J Cardiol"},{"issue":"12","key":"1529_CR40","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.amjcard.2011.02.331","volume":"107","author":"AP Amin","year":"2011","unstructured":"Amin AP, Kennedy KF, Pencina M, Berger P, Piana RN, Lopez J, Kleiman N, Cohen DJ, Event Investigators (2011) Effect of clopidogrel pretreatment on ischemic complications of percutaneous coronary intervention among bivalirudin-treated patients (from the EVENT registry). Am J Cardiol 107(12):1751\u20131756","journal-title":"Am J Cardiol"},{"issue":"3","key":"1529_CR41","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.amjcard.2009.09.034","volume":"105","author":"DN Feldman","year":"2010","unstructured":"Feldman DN, Fakorede F, Minutello RM, Bergman G, Moussa I, Wong SC (2010) Efficacy of high-dose clopidogrel treatment (600\u00a0mg) less than two hours before percutaneous coronary intervention in patients with non\u2013ST-segment elevation acute coronary syndromes. Am J Cardiol 105(3):323\u2013332","journal-title":"Am J Cardiol"},{"issue":"20","key":"1529_CR42","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","volume":"357","author":"SD Wiviott","year":"2007","unstructured":"Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann F-J, Ardissino D, De Servi S, Murphy SA (2007) Prasugrel versus clopidogrel in patients with acute coronary syndromes. New Engl J Med 357(20):2001\u20132015","journal-title":"New Engl J Med"},{"issue":"6","key":"1529_CR43","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s12471-011-0105-5","volume":"19","author":"N Breet","year":"2011","unstructured":"Breet N, van Donkersgoed H, van Werkum J, Bouman H, Kelder J, Zijlstra F, Hackeng C, Ten Berg J (2011) Is platelet inhibition due to thienopyridines increased in elderly patients, in patients with previous stroke and patients with low body weight as a possible explanation of an increased bleeding risk? Neth Heart J 19(6):279\u2013284","journal-title":"Neth Heart J"},{"issue":"11","key":"1529_CR44","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.jacc.2004.08.060","volume":"44","author":"DE Kandzari","year":"2004","unstructured":"Kandzari DE, Berger PB, Kastrati A, Steinhubl SR, Mehilli J, Dotzer F, Jurri\u00ebn M, Neumann F-J, Bollwein H, Dirschinger J (2004) Influence of treatment duration with a 600-mg dose of clopidogrel before percutaneous coronary revascularization. J Am Coll Cardiol 44(11):2133\u20132136","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"1529_CR45","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.ahj.2007.12.002","volume":"155","author":"DP Chew","year":"2008","unstructured":"Chew DP, Mahaffey KW, White HD, Huang Z, Hoekstra JW, Ferguson JJ, Califf RM, Aylward PE (2008) Coronary artery bypass surgery in patients with acute coronary syndromes is difficult to predict. Am Heart J 155(5):841\u2013847","journal-title":"Am Heart J"},{"issue":"2","key":"1529_CR46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11239-007-0016-x","volume":"24","author":"DS McLean","year":"2007","unstructured":"McLean DS, Sabatine MS, Guo W, McCabe CH, Cannon CP (2007) Benefits and risks of clopidogrel pretreatment before coronary artery bypass grafting in patients with ST-elevation myocardial infarction treated with fibrinolytics in CLARITY-TIMI 28. J Thromb Thrombolysis 24(2):85\u201391","journal-title":"J Thromb Thrombolysis"},{"issue":"10","key":"1529_CR47","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/01.CIR.0000140675.85342.1B","volume":"110","author":"KA Fox","year":"2004","unstructured":"Fox KA, Mehta SR, Peters R, Zhao F, Lakkis N, Gersh BJ, Yusuf S (2004) Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome the clopidogrel in unstable angina to prevent recurrent ischemic events (CURE) trial. Circulation 110(10):1202\u20131208","journal-title":"Circulation"},{"issue":"2","key":"1529_CR48","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jacc.2006.04.029","volume":"48","author":"RH Mehta","year":"2006","unstructured":"Mehta RH, Roe MT, Mulgund J, Ohman EM, Cannon CP, Gibler WB, Pollack CV, Smith SC, Ferguson TB, Peterson ED (2006) Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery. J Am Coll Cardiol 48(2):281\u2013286","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"1529_CR49","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.jacc.2009.03.006","volume":"53","author":"R Ebrahimi","year":"2009","unstructured":"Ebrahimi R, Dyke C, Mehran R, Manoukian SV, Feit F, Cox DA, Gersh BJ, Ohman EM, White HD, Moses JW (2009) Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. J Am Coll Cardiol 53(21):1965\u20131972","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"1529_CR50","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jtcvs.2011.01.069","volume":"143","author":"F Biancari","year":"2012","unstructured":"Biancari F, Airaksinen KJ, Lip GY (2012) Benefits and risks of using clopidogrel before coronary artery bypass surgery: systematic review and meta-analysis of randomized trials and observational studies. J Thorac Cardiovasc Surg 143(3):665\u2013675","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"18","key":"1529_CR51","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.jacc.2010.02.005","volume":"55","author":"ED Peterson","year":"2010","unstructured":"Peterson ED, Dai D, DeLong ER, Brennan JM, Singh M, Rao SV, Shaw RE, Roe MT, Ho KK, Klein LW (2010) Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. J Am Coll Cardiol 55(18):1923\u20131932","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1529_CR52","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jacc.2008.09.030","volume":"53","author":"DB Diercks","year":"2009","unstructured":"Diercks DB, Kontos MC, Chen AY, Pollack CV, Wiviott SD, Rumsfeld JS, Magid DJ, Gibler WB, Cannon CP, Peterson ED (2009) Utilization and impact of pre-hospital electrocardiograms for patients with acute ST-segment elevation myocardial infarction: data from the NCDR (National Cardiovascular Data Registry) ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry. J Am Coll Cardiol 53(2):161\u2013166","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1529_CR53","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","volume":"61","author":"PT O\u2019Gara","year":"2013","unstructured":"O\u2019Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX (2013) 2013 ACCF\/AHA Guideline for the management of ST-elevation myocardial Infarction a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 61(4):e78\u2013e140. doi:\n                        10.1016\/j.jacc.2012.11.019","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1529_CR54","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/hrt.50.2.127","volume":"50","author":"E Falk","year":"1983","unstructured":"Falk E (1983) Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J 50(2):127\u2013134","journal-title":"Br Heart J"},{"issue":"10","key":"1529_CR55","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJMoa0907272","volume":"362","author":"MR Patel","year":"2010","unstructured":"Patel MR, Peterson ED, Dai D, Brennan JM, Redberg RF, Anderson HV, Brindis RG, Douglas PS (2010) Low diagnostic yield of elective coronary angiography. New Engl J Med 362(10):886\u2013895","journal-title":"New Engl J Med"},{"issue":"4","key":"1529_CR56","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s11886-011-0184-3","volume":"13","author":"CW Good","year":"2011","unstructured":"Good CW, Berger PB (2011) P2Y12 antagonists in acute coronary syndrome: in whom should they be started, and when? Curr Cardiol Rep 13(4):320\u2013326","journal-title":"Curr Cardiol Rep"},{"issue":"24","key":"1529_CR57","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","volume":"64","author":"EA Amsterdam","year":"2014","unstructured":"Amsterdam EA, Wenger NK, Brindis RG, Casey DE, Ganiats TG, Holmes DR, Jaffe AS, Jneid H, Kelly RF, Kontos MC (2014) 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 64(24):e139\u2013e228","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-017-1529-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-017-1529-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-017-1529-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,27]],"date-time":"2017-09-27T08:23:31Z","timestamp":1506500611000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-017-1529-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,20]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["1529"],"URL":"https:\/\/doi.org\/10.1007\/s11239-017-1529-6","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,20]]}}}